{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:38:41Z","timestamp":1780047521727,"version":"3.53.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jdsjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jdermsci.2025.02.001","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T07:29:48Z","timestamp":1739777388000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role and mechanism of JAK2 inhibitor in endothelial mesenchymal transition in systemic sclerosis"],"prefix":"10.1016","volume":"117","author":[{"given":"Qingyan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2025.02.001_bib1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib3","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib4","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2025.02.001_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib7","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/rheumatology\/kez532","article-title":"The clinical and economic burden of systemic sclerosis related interstitial lung disease","volume":"59","author":"Morrisroe","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jdermsci.2025.02.001_bib8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib11","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3899\/jrheum.150088","article-title":"The endothelial-mesenchymal transition in systemic sclerosis is induced by endothelin-1 and transforming growth factor-\u03b2 and may be blocked by macitentan, a dual endothelin-1 receptor antagonist","volume":"42","author":"Cipriani","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13075-015-0754-7","article-title":"Macitentan inhibits the transforming growth factor-\u03b2 profibrotic action, blocking the signaling mediated by the ETR\/T\u03b2RI complex in systemic sclerosis dermal fibroblasts","volume":"17","author":"Cipriani","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/BOR.0000000000000112","article-title":"Endothelial dysfunction in systemic sclerosis","volume":"26","author":"Altorok","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00296-016-3636-7","article-title":"Interstitial lung disease in systemic sclerosis: current and future treatment","volume":"37","author":"Giacomelli","year":"2017","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrneph.2017.183","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"14","author":"Woodworth","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib16","first-page":"1488","article-title":"Linking myofibroblast generation and microvascular alteration: the role of CD248 from pathogenesis to therapeutic target (Review)","volume":"20","author":"Di Benedetto","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib17","doi-asserted-by":"crossref","DOI":"10.5152\/eurjrheum.2019.19158","article-title":"Endothelial cells and endothelial progenitor cells in the pathogenesis of systemic sclerosis","volume":"7","author":"Ota","year":"2020","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12016-021-08889-8","article-title":"Current concepts on the pathogenesis of systemic sclerosis","volume":"64","author":"Truchetet","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1042\/BST20110723","article-title":"New insights into the plasticity of the endothelial phenotype","volume":"39","author":"Cooley","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14361","article-title":"The molecular basis of endothelial cell plasticity","volume":"8","author":"Dejana","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib22","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/BOR.0000000000000217","article-title":"Origin of fibrosing cells in systemic sclerosis","volume":"27","author":"Ebmeier","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00441-011-1190-x","article-title":"Role of Smads in TGF\u03b2 signaling","volume":"347","author":"Heldin","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","article-title":"Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases","volume":"99","author":"Piera-Velazquez","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(21)00438-4","article-title":"Current and future status of JAK inhibitors","volume":"398","author":"McLornan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2025.02.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103168","article-title":"JAK inhibitors and systemic sclerosis: a systematic review of the literature","volume":"21","author":"Moriana","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib29","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/annrheumdis-2016-210104","article-title":"Filgotinib (GLPG0634\/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)","volume":"76","author":"Westhovens","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/bjd.14018","article-title":"Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials","volume":"173","author":"Papp","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.859330","article-title":"JAK1\/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis","volume":"9","author":"Hou","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib32","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/art.34500","article-title":"JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor \u03b2 in systemic sclerosis","volume":"64","author":"Dees","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib33","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.7150\/thno.94121","article-title":"Dynamic pathological analysis reveals a protective role against skin fibrosis for TREM2-dependent macrophages","volume":"14","author":"Liang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.jdermsci.2025.02.001_bib34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/BJ20101500","article-title":"Transforming growth factor-\u03b22 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling","volume":"437","author":"Medici","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib35","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib36","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/ard.2009.127621","article-title":"Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma","volume":"70","author":"Domsic","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrrheum.2010.102","article-title":"Cellular and molecular aspects of vascular dysfunction in systemic sclerosis","volume":"6","author":"Trojanowska","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105968","article-title":"Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt\/mTOR\/p70S6K pathway in a murine model of systemic sclerosis","volume":"77","author":"Jiang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/835948","article-title":"Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis","volume":"2013","author":"Jimenez","year":"2013","journal-title":"ISRN Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib42","doi-asserted-by":"crossref","first-page":"4636859","DOI":"10.1155\/2016\/4636859","article-title":"Vascular remodelling and mesenchymal transition in systemic sclerosis","volume":"2016","author":"Nicolosi","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10157-013-0781-0","article-title":"Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease","volume":"17","author":"He","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2217\/imt-2020-0270","article-title":"The rationale for targeting the JAK\/STAT pathway in scleroderma-associated interstitial lung disease","volume":"13","author":"Talotta","year":"2021","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jdermsci.2025.02.001_bib45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12016-020-08786-6","article-title":"JAK inhibitors: prospects in connective tissue diseases","volume":"59","author":"You","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cellsig.2012.10.003","article-title":"TGF-\u03b2 signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities","volume":"25","author":"Samarakoon","year":"2013","journal-title":"Cell Signal."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib47","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","article-title":"Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib48","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.41192","article-title":"Promotion of myofibroblast differentiation and tissue fibrosis by the leukotriene B(4) -leukotriene B(4) receptor axis in systemic sclerosis","volume":"72","author":"Liang","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2025.02.001_bib49","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00089.2020","article-title":"DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K\/Akt\/mTOR signaling pathway","volume":"320","author":"He","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181125000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181125000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T11:44:48Z","timestamp":1742039088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181125000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0923181125000179"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2025.02.001","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role and mechanism of JAK2 inhibitor in endothelial mesenchymal transition in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2025.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}